Recursion Pharmaceuticals
RXRX
#5082
Rank
A$2.62 B
Marketcap
A$4.21
Share price
3.86%
Change (1 day)
-34.14%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2026 (TTM): -A$0.7 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are A$67.01 Million. In 2025 the company made an earning of -A$0.96 Billion a decrease over its 2024 earnings that were of -A$0.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.7 Billion-27.22%
2025 -A$0.96 Billion38.83%
2024 -A$0.7 Billion39.51%
2023 -A$0.5 Billion38.68%
2022 -A$0.36 Billion30.46%
2021 -A$0.28 Billion114.28%
2020 -A$0.13 Billion